Sylvia Hsu Selected Research

Sylvia Hsu Research Topics

Disease

35	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024 - 05/2004
8	Infections 01/2022 - 01/2005
7	Bullous Pemphigoid (Pemphigoid) 09/2022 - 06/2004
6	Pemphigus (Pemphigus Vulgaris) 09/2022 - 01/2016
6	Neoplasms (Cancer) 09/2021 - 05/2004
5	Skin Diseases (Skin Disease) 10/2022 - 12/2016
5	Acne Vulgaris 04/2020 - 04/2006
4	Pyoderma Gangrenosum 11/2022 - 08/2003
4	Stevens-Johnson Syndrome (Lyell's Syndrome) 10/2022 - 12/2003
4	Sarcoidosis (Schaumann Disease) 05/2021 - 08/2003
3	Tuberculosis (Tuberculoses) 10/2023 - 01/2008
3	Linear IgA Bullous Dermatosis 10/2022 - 06/2004
3	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 09/2022 - 11/2019
3	Melanoma (Melanoma, Malignant) 01/2021 - 04/2012
3	Vitiligo 09/2019 - 05/2007
3	Prurigo 01/2019 - 08/2003
3	Lichen Planus (Lichen Ruber Planus) 07/2010 - 08/2003
3	Erythema Nodosum 07/2010 - 08/2003
3	Crohn Disease (Crohn's Disease) 01/2008 - 05/2004
2	Psoriatic Arthritis 03/2024 - 08/2008
2	Acneiform Eruptions 08/2023 - 01/2008
2	Pruritus (Itching) 08/2022 - 07/2010
2	Atopic Dermatitis (Atopic Eczema) 06/2022 - 08/2005
2	Asthma (Bronchial Asthma) 06/2022 - 08/2005
2	Blister (Bulla) 02/2022 - 11/2019
2	Persistent Infection 01/2022 - 12/2009
2	Burnett Schwartz Berberian syndrome 01/2022 - 04/2012
2	Chronic Urticaria 01/2022 - 01/2022
2	Rocky Mountain Spotted Fever (Sao Paulo Typhus) 01/2021 - 02/2014
2	Drug Eruptions (Drug Eruption) 04/2016 - 12/2009
2	Hepatitis B 01/2014 - 01/2012
2	Amyloidosis 04/2013 - 06/2006
2	Hepatitis C 04/2011 - 01/2005
2	Necrobiosis Lipoidica 07/2010 - 12/2009
2	Aphthous Stomatitis (Aphthous Ulcer) 07/2010 - 08/2003
2	Rheumatoid Arthritis 09/2008 - 01/2008
2	Edema (Dropsy) 01/2008 - 05/2004
2	Necrosis 11/2005 - 05/2004
1	Flushing 10/2023
1	Cutaneous Lupus Erythematosus 05/2023
1	Pemphigoid Gestationis (Herpes Gestationis) 09/2022
1	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 09/2022
1	Dermatomyositis (Dermatopolymyositis) 08/2022
1	Allergic Rhinitis 06/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

13	Infliximab (Remicade)FDA Link 12/2021 - 05/2004
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2005
8	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 08/2008
7	Adalimumab (Humira)FDA Link 12/2021 - 11/2005
6	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2023 - 07/2006
5	AntibodiesIBA 02/2022 - 11/2005
5	Etanercept (Enbrel)FDA Link 12/2021 - 11/2005
5	Methotrexate (Mexate)FDA LinkGeneric 12/2016 - 08/2008
5	Tumor Necrosis Factor InhibitorsIBA 01/2014 - 11/2005
4	Immunoglobulin A (IgA)IBA 10/2022 - 06/2004
4	dupilumabIBA 08/2022 - 01/2019
4	secukinumabIBA 12/2021 - 04/2016
4	Thalidomide (Thalomid)FDA Link 07/2010 - 08/2003
3	Omalizumab (Xolair)FDA Link 01/2022 - 08/2005
3	Ustekinumab (CNTO 1275)FDA Link 12/2021 - 09/2011
3	brodalumabIBA 12/2021 - 01/2017
3	SulfonamidesIBA 01/2021 - 08/2011
3	SteroidsIBA 09/2012 - 04/2006
3	Acitretin FDA Link 08/2012 - 05/2006
2	InterleukinsIBA 08/2022 - 12/2021
2	Histamine Antagonists (Antihistamines)IBA 01/2022 - 01/2022
2	Tuberculin (PPD)IBA 04/2021 - 01/2008
2	pembrolizumabIBA 05/2020 - 04/2019
2	Terbinafine (Lamisil)FDA LinkGeneric 11/2019 - 07/2018
2	AutoantibodiesIBA 11/2019 - 06/2004
2	MucinsIBA 10/2018 - 10/2004
2	Fluconazole (Zonal)FDA LinkGeneric 04/2016 - 04/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2014 - 10/2008
2	Alefacept (Amevive)FDA Link 09/2011 - 01/2008
2	Minocycline (Cyclops)FDA LinkGeneric 08/2011 - 04/2006
2	Isotretinoin (Accutane)FDA LinkGeneric 10/2008 - 01/2008
2	CytokinesIBA 08/2008 - 01/2005
1	Immunomodulating AgentsIBA 03/2024
1	spesolimabIBA 10/2023
1	Tacrolimus (Prograf)FDA LinkGeneric 10/2023
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 08/2023
1	apremilastIBA 01/2023
1	Interleukin-13IBA 08/2022
1	SaltsIBA 02/2022
1	ImmunosorbentsIBA 02/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Certolizumab Pegol FDA Link 12/2021
1	risankizumabIBA 12/2021
1	Interleukin-12 (IL 12)IBA 12/2021
1	tildrakizumabIBA 12/2021
1	Interleukin-23 (Interleukin 23)IBA 12/2021

Therapy/Procedure

29	Therapeutics 06/2022 - 01/2005
6	Biological Therapy 06/2022 - 11/2005
3	Drug Therapy (Chemotherapy) 09/2020 - 09/2005
3	Off-Label Use 07/2010 - 08/2003
2	Immunomodulation 01/2022 - 08/2008
2	Contraindications 01/2021 - 12/2009
2	Phototherapy (Light Therapy) 09/2011 - 12/2009
1	Ostomy 11/2022